The Administration Core acts to ensure that the research and programmatic goals of the Healthy Aging and Senile Dementia program project grant (HASD PPG) are met. The administrative leadership consists of the Director (Morris) and the Executive Director (Moulder). They are assisted by the Executive Committee that includes these individuals, leaders of Cores and Projects, and other senior faculty. The Administration Core supports, monitors, and coordinates the activities of all components of the HASD PPG. It will annually convene an External Advisory Committee to review activities and progress.
The specific aims are to: 1) Coordinate and integrate all Cores and Projects and monitor the effectiveness of the PPG toward achieving the stated goals. 2) Provide administrative and budgetary support and oversight to the Cores and Projects, ensuring appropriate utilization of the funds in all PPG activities. 3) Arrange for periodic external review and advice regarding PPG goals and programs. 4) Provide oversight and administrative support for data integration with Core C: Biostatistics to maintain and monitor an integrated database for the PPG 5) Coordinate the collaborations between Core E: Imaging and Avid/Lilly regarding amyloid imaging with [18F]florbetapir 6) Facilitate inclusion of HASD participants and data in other national AD initiatives, including the Alzheimer's Disease Neuroimaging Initiative (ADNI), the Alzheimer's Disease Genetics Consortium (ADGC), trials orchestrated by the Alzheimer's Disease Cooperative Study (ADCS), and as acceptable, the National Alzheimer Coordinating Center (NACC).
Core A: Administration Project Narrative As instructed by the funding opportunity announcement for this application (PAR-13-329), only the Overall component contains a project narrative. Cores and projects were instructed not to include this section.
|Su, Yi; Blazey, Tyler M; Snyder, Abraham Z et al. (2015) Partial volume correction in quantitative amyloid imaging. Neuroimage 107:55-64|
|Shim, Yong Soo; Yang, Dong-Won; Roe, Catherine M et al. (2015) Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dement Geriatr Cogn Disord 39:92-104|
|Wang, Li-San; Naj, Adam C; Graham, Robert R et al. (2015) Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol 72:209-16|
|Ghoshal, Nupur; Perry, Arie; McKeel, Daniel et al. (2015) Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old. Alzheimer Dis Assoc Disord 29:173-6|
|Hurth, Kyle; Tarawneh, Rawan; Ghoshal, Nupur et al. (2015) Whipple's disease masquerades as dementia with Lewy bodies. Alzheimer Dis Assoc Disord 29:85-9|
|Aschenbrenner, Andrew J; Balota, David A; Tse, Chi-Shing et al. (2015) Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults. Neuropsychology 29:368-81|
|Lim, Miranda M; Gerstner, Jason R; Holtzman, David M (2014) The sleep-wake cycle and Alzheimer's disease: what do we know? Neurodegener Dis Manag 4:351-62|
|Pizzie, Rachel; Hindman, Halley; Roe, Catherine M et al. (2014) Physical activity and cognitive trajectories in cognitively normal adults: the adult children study. Alzheimer Dis Assoc Disord 28:50-7|
|Fagan, Anne M; Xiong, Chengjie; Jasielec, Mateusz S et al. (2014) Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med 6:226ra30|
|Harari, Oscar; Cruchaga, Carlos; Kauwe, John S K et al. (2014) Phosphorylated tau-A?42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid. Biol Psychiatry 75:723-31|
Showing the most recent 10 out of 529 publications